Product Information

ZITUVIMET XR 100-1,000 MG TAB is a brand product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $10.0694 per EA under NDC 70710180603. Its NADAC has been published 66 times since May 21, 2025.

FDA first approved this application on Jul 18, 2024.

ZITUVIMET XR 100-1,000 MG TAB

sitagliptin and metformin hydrochloride
$10.0694per EA

Strength

1000; 100 mg/1; mg/1

NDC

70710180603

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA216778

FDA Approved

7/18/2024

On Market Since

10/31/2024

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for ZITUVIMET XR 100-1,000 MG TAB has been published 66 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$10.0694 per EA
All-time high$10.1233 (Jun 11, 2025)
All-time low$10.0435 (Jul 22, 2026)
52-week high$10.0694
52-week low$10.0435
Median price$10.0550
Average price$10.0624
Largest weekly change-0.3% (Jun 18, 2025)
Weeks tracked66
Tracking sinceMay 21, 2025

Price History

1W

+0.3%

1M

+0.3%

3M

+0.2%

6M

+0.1%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

-0.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZITUVIMET XR 100-1,000 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ZITUVIMET XR 100-1,000 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $10.0694 per EA (NDC 70710180603), effective Aug 19, 2026.

How has the price of ZITUVIMET XR 100-1,000 MG TAB changed over time?

Over the history we have for it, the NADAC for ZITUVIMET XR 100-1,000 MG TAB has held within roughly two percent of its current level. It has been tracked across 66 weekly CMS publications since May 21, 2025.

What are the highest and lowest recorded NADAC prices for ZITUVIMET XR 100-1,000 MG TAB?

Since May 21, 2025, the NADAC for ZITUVIMET XR 100-1,000 MG TAB has ranged from a low of $10.0435 (Jul 22, 2026) to a high of $10.1233 (Jun 11, 2025), with a median of $10.0550 per EA.

Are there cheaper alternatives to ZITUVIMET XR 100-1,000 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZITUVIMET XR 100-1,000 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ZITUVIMET XR 100-1,000 MG TAB?

ZITUVIMET XR 100-1,000 MG TAB (NDC 70710180603) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a brand product.